The Harvard research funding crisis has plunged the university's groundbreaking projects into uncertainty, marking a pivotal moment for officials and researchers alike.Just hours following Harvard's rejection of the Trump administration's demands, a stop-work order targeted pivotal organ-on-a-chip technology studies led by Don Ingber, impacting over $19 million in contracts.